mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.03 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |